Dr. Rashid Khan just posted the top five reasons to be concerned with non-alcoholic fatty liver disease. A growing public health concern, fatty liver continues to cause a wide range of medical complication that need to be taken seriously. If you have fatty liver, you need further evaluation. Read his blog entry here.
Save the date! Dr. Galati's first Town Hall Meeting, which is being called the "Wake-Up Call, will take place at Houston's Health Museum, on Thursday, November 5, 2015, starting at 6:00 p.m. Sponsored by Your Health First Education, the mission of this event is to provide the lay public with the tools necessary to engage themselves, and those closest to them, in a discussion of health and wellness. So many complications of various diseases could be prevented, or diagnosed earlier, reducing complications, and far better outcomes. This "wake-up call" is to tell everyone that being a bit more aware of their body, and better understanding of how it works, will lead to far improved health and happiness. Information about the event: Location: Houston Health Museum Address: 1515 Hermann Drive, Houston, Texas 77004 Time: 6:00 p.m. - 9:00 p.m. Free parking, …
Listed below are the updated hepatitis C research protocols that Liver Specialists of Texas and Dr. Galati are currently conducting. The studies are in various stages of enrollment, and some may have already met the limit of how many patients we can enroll. A PDF version is available here. New studies are being added every few weeks, so depending on your situation, and past experience with hepatitis C treatment, new opportunities may be available soon. Currently, the ongoing studies are making use of both interferon based therapies, as well as interferon-free therapies. It is probable that the next wave of FDA approvals will be for the interferon-free protocols. Kindly call Dee Wade at 713-794-0700 to inquire about hepatitis C research opportunities. Research Specialists of Texas List of Ongoing Studies No. Sponsor Protocol # Protocol …
A You Tube video of the announcement by Dr. Joe Galati is posted, discussing how Liver Specialists of Texas will evaluate and treat both new and old patients with Boceprevir. After years of research, and great anticipation by patients and physicians involved in the care of patients with hepatitis C, Boceprevier was finially approved yesterday. Yesterday was a very important day for those of us involved in the care of patients with hepatitis C, as well as the millions of individuals affected by it. I received word yesterday afternoon that the FDA has approved boceprevir for the treatment of G1 CHC in previously untreated patients and patients who have failed previous interferon and ribavirin therapy. Boceprevir is the first in class direct acting antiviral to be FDA approved for CHC. Manufactured by Merck pharmaceutical company, the …
In this podcast, Dr. Joe Galati discusses the liver transplant evaluation process that is used at The Methodist Hospital Center for Liver Disease and Transplantation. Individuals with end-stage liver disease, who have experienced various complication of cirrhosis, are considered for transplantation. Diseases that lead to cirrhosis include the following: chronic hepatitis C, chronic hepatitis B, alcoholic liver disease, non-alcoholic fatty liver, autoimmune disorders, and other genetic disorders of the liver. The evaluation process usually takes place as an out-patient, where you are seen by one of our liver transplant surgeons, as well as specialized nurse coordinators, social worker, dietitian, financial counselors, and other medical specialists such as cardiology, psychiatry, and lung specialists as needed. Once evaluated and approved, patients are listed for transplant. Priority for transplant is based on the MELD score. The higher the MELD score, the …
HALFLYTELY BOWEL PREP INSTRUCTIONS NOTE: Before beginning the following steps, have your prescription for Halflytely® filled. THE DAY BEFORE YOUR PROCEDURE: *Make sure to take the Bisacodyl tablets at 10a.m. then wait 6 hours to start Halflytely® *CLEAR LIQUIDS ONLY, ALL DAY BEFORE PROCEDURE. Clear liquids include black coffee or tea, clear fruit juices (apple or white grape), broth or bouillon, non-red gelatin dessert, Sprite, Gatorade and Ginger ale. 1. In the morning, after a clear liquid breakfast, prepare your Halflytely® solution according to the instructions on the package and refrigerate. 2. Have a clear liquid lunch. 3. By 10 a.m. – Begin by taking the 2 time released Bisacodyl tablets provided in the prep kit box. 4. At 4 p.m. – begin drinking Halflytely® as instructed – 8 oz. every 10-15 minutes until the bottle is empty. (Rapidly …
Click here to read the latest press release from Liver Specialists of Texas, released September 25, 2008.
This podcast discusses the effect of cirrhosis on pregnancy. While women that have cirrhosis get pregnant less often, when women with cirrhosis do become pregnanct, there are added concerns and dangers. Complications include and increased risk of bleeding esophageal varicies, worsening hepatic function, internal bleeding, and hepatic encephalopathy. Details from the article are posted below.
Erin Yates, PA-C Liver Specialists of Texas Hepatitis is simply an inflammation of the liver. There are multiple causes of hepatitis including very common viruses such as hepatitis A, B and C. Hepatitis A virus is spread by close personal contact with someone who has the infection, eating food prepared by someone with hepatitis A or drinking contaminated water. Hepatitis B virus is a sexually transmitted disease or may be passed from a hepatitis B infected mother to child. It is not spread by shaking hands or hugging. The tables below show people at high risk of contracting hepatitis A and B. TABLE 1: High risk populations Hepatitis A (HAV) Hepatitis B (HBV) Travelers to developing countries with high rates of HAV (includes Mexico) Men who have sex with men IV drug users People exposed to hepatitis A in a research setting People who work with infected non-human primates …
Dr. Galati discusses in this podcast the various risk factors for hepatitis C, and the need to get screened for hepatitis C if you have any of these risk factors.